CHM 0.00% 1.0¢ chimeric therapeutics limited

Ann: CHM CDH17 Phase 1/2 clinical trial approved for initiation, page-2

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 12,921 Posts.
    lightbulb Created with Sketch. 3955
    Was hoping for a " First patient dosed " anns, still some hurdles to come. Probably July? Anyway, better late than never. 3rd generation, auto or allo? Allo is now the way to go but when licensed it wasn't that popular. Maybe they can use allo as well, in the end is just a matter of availability of healthy donor cells or they may use the placenta based cells developed by CELU.

    Time will tell.

    GLTA
 
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
(20min delay)
Last
1.0¢
Change
0.000(0.00%)
Mkt cap ! $9.951M
Open High Low Value Volume
1.1¢ 1.2¢ 1.0¢ $18.06K 1.681M

Buyers (Bids)

No. Vol. Price($)
6 1392859 1.0¢
 

Sellers (Offers)

Price($) Vol. No.
1.1¢ 23454 1
View Market Depth
Last trade - 15.59pm 18/11/2024 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.